Trial · NCT04620135
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Intraocular Pressure (IOP) | Netarsudil Ophthalmic Solution 0.02% and Netarsudil Ophthalmic Solution Vehicle | 15.96 | Standard Error 0.157 | mmHg | |
| Intraocular Pressure (IOP) | Ripasudil Hydrochloride Hydrate Ophthalmic Solution 0.4% | 17.71 | Standard Error 0.155 | mmHg | |
| IOP at Weeks 1 and 2 | Netarsudil Ophthalmic Solution 0.02% and Netarsudil Ophthalmic Solution Vehicle | Mean diurnal IOP at Weeks 1 (Days 8) | 16.28 | Standard Error 0.143 | mmHg |
| IOP at Weeks 1 and 2 | Ripasudil Hydrochloride Hydrate Ophthalmic Solution 0.4% | Mean diurnal IOP at Weeks 1 (Days 8) | 17.87 | Standard Error 0.141 | mmHg |
| IOP at Weeks 1 and 2 | Netarsudil Ophthalmic Solution 0.02% and Netarsudil Ophthalmic Solution Vehicle | Mean diurnal IOP at Weeks 2 (Days 15) | 16.02 | Standard Error 0.168 | mmHg |
| IOP at Weeks 1 and 2 | Ripasudil Hydrochloride Hydrate Ophthalmic Solution 0.4% | Mean diurnal IOP at Weeks 2 (Days 15) | 17.83 | Standard Error 0.166 | mmHg |
| Mean Change IOP From Baseline at Days 8, 15, 29 | Netarsudil Ophthalmic Solution 0.02% and Netarsudil Ophthalmic Solution Vehicle | Baseline IOP mean diurnal IOP | 20.475 | Standard Error 0.2510 | mmHg |
| Mean Change IOP From Baseline at Days 8, 15, 29 | Ripasudil Hydrochloride Hydrate Ophthalmic Solution 0.4% | Baseline IOP mean diurnal IOP | 20.830 | Standard Error 0.3198 | mmHg |
| Mean Change IOP From Baseline at Days 8, 15, 29 | Netarsudil Ophthalmic Solution 0.02% and Netarsudil Ophthalmic Solution Vehicle | V4: Week 1 (Day 8) Change from Baseline | -4.341 | Standard Error 0.1603 | mmHg |
| Mean Change IOP From Baseline at Days 8, 15, 29 | Ripasudil Hydrochloride Hydrate Ophthalmic Solution 0.4% | V4: Week 1 (Day 8) Change from Baseline | -2.814 | Standard Error 0.1397 | mmHg |
| Mean Change IOP From Baseline at Days 8, 15, 29 | Netarsudil Ophthalmic Solution 0.02% and Netarsudil Ophthalmic Solution Vehicle | V5: Week 2 (Day 15) Change from Baseline | -4.601 | Standard Error 0.1728 | mmHg |
| Mean Change IOP From Baseline at Days 8, 15, 29 | Ripasudil Hydrochloride Hydrate Ophthalmic Solution 0.4% | V5: Week 2 (Day 15) Change from Baseline | -2.852 | Standard Error 0.1759 | mmHg |
| Mean Change IOP From Baseline at Days 8, 15, 29 | Netarsudil Ophthalmic Solution 0.02% and Netarsudil Ophthalmic Solution Vehicle | V6: Week 4 (Day 29) Change from Baseline | -4.653 | Standard Error 0.1701 | mmHg |
| Mean Change IOP From Baseline at Days 8, 15, 29 | Ripasudil Hydrochloride Hydrate Ophthalmic Solution 0.4% | V6: Week 4 (Day 29) Change from Baseline | -2.983 | Standard Error 0.1622 | mmHg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04620135/results